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INTRODUCTION 
The Lp antigen of human serum proteins, a species of /?-lipoprotein, was first described by 
Berg (1963). Available data a t  that  time indicated that the production of the Lp antigen was 
under simple autosomal dominant genetic control. Since then several reports have cited data 
which indicate more complex control of production of this antigen (Harvie & Schultz, 1970; 
Utermann & Wiegandt, 1970; Rittner & Wichmann, 1967; Ehnholm et al. 1971, 1972). These 
more recent data favour the likelihood that the genetic variation is in levels of Lp in the sera of 
different individuals, rather than simple presence or absence of the factor. The varying quanti- 
ties of Lp antigen could represent a series of discrete levels, under the control of one or a few 
genes, or a continuous distribution of antigen under polygenic control. Non-genetic factors may 
also play a role in expression of this trait. In this communication we describe an assay for esti- 
mation of the amount of Lp antigen in human serum, and the application of this assay to a 
sample Caucasian population. Data based on this assay further supports the quantitative 
nature of the variation in Lp antigen. A bimodality of the frequency distribut>ion is identified 
which is consistent with the hypothesis of control by a major gene. 
MATERIALS AND METHODS 
The procedure chosen for quantitation of Lp antigen in normal human serum was a radio- 
immune inhibition assay. Anti-Lp antibody was combined with cyanogen bromide-activated 
sepharose (Cuatrecasas, 1970) to  form an immunoadsorbent. This immunoadsorbent was 
incubated first with the serum to be analysed and then with a standardized preparation of 
125T-labelled, partially purified Lp antigen. The amount of serum required to inhibit 60 yo of 
the maximum uptake of radioactivity by the adsorbent was taken as a measure of the Lp antigen 
in the unknown serum. The procedure is illustrated in Fig. 1.  
Immunoadsorbent 
Specific anti-Lp(a) heteroantisera were produced in rabbits against partially purified prepara- 
tions of human Lp-lipoprotein, as previously described (Schultz, Shreffler & Harvie, 1968). The 
untisera were rendered specific by absorption with /3-lipoprotein of density < 1 . 0 6 4 ~  isolated 
from the serum of an Lp(a - ) individual. This serum was identified as an Lp(a - ) serum because, 
in its unconcentrated form, it did not react with a specific anti-Lp(a) antiserum in Ouchterlony 
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Fig. 1. Schematic representation of radioimmunoassay. 
immunodiffusion. A concentrated subfraction of Lp(a - ) serum containing proteins of density 
> 1 . 1 2 0 ~  was also used in order to  absorb any trace antibodies to these proteins. The absorbing 
fractions did not contain detectable Lp(a) protein. After absorption, this antiserum gave a 
single band on Ouchterlony immunodiffusion with Lp(a + ) sera. Further details of preparation, 
absorption, characterization and specificity of anti-Lp(a) sera prepared in this laboratory have 
been previously published (Schultz et al. 1968). The specificity of the antiserum used in t'hese 
studies was checked by comparison of its reaction against a large panel of normal sera with that 
of a reference antiserum. The specificity of the reference antiserum was established in coopera- 
tive studies with Dr K. Berg. Although unavailability of completely pure Lp antigen made i t  
impossible to  obtain pure anti-Lp(a) antibody by direct immunization, exhaustive absorption 
of the antiserum eliminated the possibility of contamination by antibodies against any serum 
fractions other than Lp(a). The immune globulins from this antiserum were freed of most of the 
contaminating proteins which might interfere with their attachment to sepharose by removal 
of the excess P-lipoprotein added for absorption, followed by (NH,),SO, precipitation. The 
antisera were adjusted to  a density of 1 . 2 1 ~  by addition of 0.32 g. of NaBr per ml. of serum and 
dialysed against NaBr of density 1 . 2 1 ~ .  The material was then centrifuged in a preparative 
ultra-centrifuge for 44 hr. a t  100,000 g. The least dense fraction containing 115 of the total 
volume and all P-lipoprotein antigenic activity was removed. The antibody-rich y-globulin was 
then precipitated according to  a modification of the method of Kendall ( 1937). To the remaining 
P-lipoprotein-free fractions, containing 415 of the original serum volume, 0.5 ml. of a saturated 
solution of (NH,),SO, was added. The mixture was allowed to  stand for 1 hr. a t  room tempera- 
ture and the precipitate that formed was separated by centrifugation. 
The supernatant was removed and the precipitate redissolved in 1 ml. of phosphate buffered 
saline and dialysed overnight a t  4" C. against phosphate buffered saline. Ouchterlony tests 
showed that all anti-Lp activity was found in the dissolved precipitate with none remaining in 
the supernatant. 
This antibody preparation was attached to  sepharose 4 B  to form the required immuno- 
adsorbent by a modification of the cyanogen bromide activation method of Cuatrecasas (1970). 
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Sephararose 4B was washed three times in distilled water, allowed to  settle, and the water 
decanted. Distilled water equal to onelhalf of the volume of the water removed was added, the 
suspension cooled to  20" C. and then onelhalf volume of cyanogen bromide solution containing 
3-0 g./5 ml. was added to  the sepharose. Temperature was maintained a t  20" C. and pH ad- 
justed to 10.5 until the pH no longer tended to drop (a maximum of 12 minutes) indicating the 
complete activation of the sepharose. The reaction mixture was immediately transferred to a 
coarse disc Buchner funnel maintained at  4" C. and washed under suction with 15 times the 
sepharose volume of cold 1 M-NaHCO,. Suction was terminated and the partially purified anti- 
Lp serum (approximately 10 mg. antibody per 5 ml. sepharose) prepared as described above 
was immediately added to  the Buchner funnel. The mixture was then transferred to a beaker 
and allowed to react a t  4" C. for 16-20 hr. with gentle stirring. 
The immunoadsorbent was washed with five 100 ml. portions of 0.1 M-NaHCO, and stored 
for future use in 3 vols. of 0.1 M-NaHCo, a t  4" C. Before use in the assay procedure, the immuno- 
adsorbent was diluted 1 part to  30 parts of a modified 'assay buffer' as described by Wide 
(1969), consisting of 80 ml. 0.5 M sodium barbital, 12 ml. 5.0 M-NaCI, and 5.3 ml. 2 N-HCl in 
2 1. to which were added 3 g./100 ml. bovine serum albumin and 0.5 m1.1100 ml. NP-40 deter- 
gent (Shell Chemicals, U.K., Limited, London). 
Preparation of [1251]Lp antigen 
Lp lipoproteins were concentrated and partially purified as described elsewhere (Schultz 
et al. 1968). The concentrated solutions of Lp antigen were iodinated with 1251 (New England 
Nuclear) according to  the method of Reif (1967) employing IC1. The method of Greenwood, 
Hunter & Glover (1963) which employs chloramine T in the iodination procedure was found to  
destroy the antigenic activity of the Lp protein. 
Standardization of the assay 
The ratio of immunoadsorbent to labelled Lp preparation that was needed in an assay varied 
somewhat with each batch of reagents and therefore optimal ratios were determined each time 
a batch of reagents was prepared. 
Various amounts of immunoadsorbent suspension containing 0.1 -+ 1.0 ml. of a 1/30 dilution 
of standard suspension in assay buffer was mixed with 10 --f 100 pl. amounts of labelled antigen 
solution. A standard curve was prepared as shown in Fig. 2. It should be noted that the curves 
are identical for all levels of immunoadsorbent greater than 0.3 ml., therefore 0.3 ml. was con- 
sidered the optimal quantity of immunoadsorbent for this particular batch of reagent. For each 
batch of immunoadsorbent and each batch of iodinated Lp preparation, the amount of the 
latter which would give a slight excess of antigen over antibody content of immunoadsorbent 
was determined. The same levels of antibody preparation (immunoadsorbent) and 1251-labelled 
antigen were then used for each determination in which a given batch of reagent was employed. 
Radioimmunoassay 
Reactions of unknowns with standardized immunoadsorbent were carried out in 3 ml. glass 
test-tubes which had been siliconized (Siliclad, Clay Adams) according to the manufacturer's 
directions. A standard amount of immunoadsorbent, kept in suspension by stirring on a mag- 
netic stirrer, was pipetted into each siliconized tube followed by a volume of the serum t,o be 
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Fig. 2. Standard ciin’c’ for iniiniiiioadsorberit assay. 0-0, 0.1 ml. irntnulloadsorheilt,; G-Q, 
0.3 i d .  iminunoadsorbent; A-A, 0.5 ml. iinmunoadsorbent; 0-U, 0.7 nil. iinrnunotldsorhc.rit. 
quantitatively analysed as described below. The volume of the reaction mixture was then 
adjusted to  a total volume of 1 ml. and rotated slowly for 16 hr. at 4” C. on a rotary mixer 
(Scientific Industries, Inc., Queens Village, N.Y.). An antigen excess quantity of 1251-labelled Lp 
protein preparation was then added t o  each tube and the mixture was rotated for an additional 
16 hr. Samples were washed four times with 1 ml. of 0.5 yo NP-40 detergent in phosphate 
buffered saline and centrifuged each time in a clinical centrifuge (International Equipment Co., 
Boston, Mass). Samples were then counted in a gamma counter (Nuclear-Chicago Gorp.). 
Each serum to be analyzed was first pretested by Ouchterlony immunodiffusion and scored 
as a positive, weak positive or negative reactor as previously described (Schultz et al. 1968; 
Schultz, 1970). All samples were tested in the radioimmunoassay in duplicate and, with each 
group of samples, a sample inhibited by 25 pl. of a standard very strong Lp(a) serum and tin 
uninhibited sample were included to  find the limits of minimum and maximum uptake of 
lZ5I-labelled antigen by the immunoadsorbent. The quantity of Lp(a) serum used in the mini- 
mum uptake sample was shown to be in gross antigen excess for all immunoadsorbent prepara- 
tions. 
A serum which was a strong Lp(a+)  in Ouchterlony test was initially sampled at  a level of 
5 pl. of a 1: 1 dilution of serum in phosphate buffered saline for use in the assay. To test a ‘nega- 
tive’ serum 10 pl. of undiluted serum was used in the assay. Some of the samples were not on 
the linear portion of the inhibition curve (see fig. 2 )  and the determination was repeated with 
the sample size adjusted accordingly. 
Calculations 
The volume of undiluted serum required to inhibit the immunoadsorbent pickup of 1251- 
labelled Lp protein by 50 yo was used as the quantitative indication of Lp antigen in the sample. 
This amount of serum was estimated graphically as shown in Fig. 3. The amount of strongest 
positive serum to give 50% inhibition was arbitrarily assigned a value of 1 and all other Lp 
‘concentrations’ were based on this value. The values obtained are therefore relative rather 
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Fig. 3. Amounts of [1251]Lp absorbed by immunoadsorbent after preabsorption with various 
amounts of unknown serum. A = Maximum capacity of immunoadsorbent (countslmin). 
B = Background capacity of immunoadsorbent (countslmin). C = l /2  ( A  + B). D = Unknown, 
gives D' counts with D'h. B* = Interpolated amount of unknown serum that would cause a 50 yo 
reduction in anti-Lpa-lZ51 absorption by the immurio adsorbent [intersection of lines AD and C]. 
S = as point D but for standard strong Lp(a) serum. S* = as point B* but for standard strong 
Lp(a) serum. Relative amount of Lp antigen in unknown sample = S*/B*. 
than absolute values. The relative Lp units in the unknown serum were calculated according 
to  the formula: 
relative Lp units in unknown serum 
h of strongest Lp serum needed for 50 % inhibition of immunoadsorbent (S*) 
B* (see Fig. 3 legend) 
- 
RESULTS AND DISCUSSION 
One hundred and forty-six serum samples obtained from the Serology Laboratory a t  the 
University of Michigan Hospital were scored for relative amounts of Lp antigen in the manner 
described above. The distribution of the relative Lp units in this population is shown in Fig. 4. 
Relative values ranged from 0.021 arbitrary units for an Lp(a - ) serum to 1.00 for the strongest 
Lp(a + ) serum used as standard. The mean value was 0.306 and the standard deviation 0.26. 
The frequency distribution of this relative quantitative measure in the total sample population 
is positively skewed. 
The measurement method described above results in a non-additive change in the ratio 
S*IB* as B* changes linearly. Previously we have considered a frequency distribution of quan- 
titative levels based on the ratio S*IB* (Schultz & Shreffler, 1973). However, the non-additive 
change in scale of this ratio has prompted us to consider the use of log, of S*IB* as the variable 
of study. Since S* is a constant, the log, S*/B* ( = log, S* -log, B*) will be a function of varia- 
tion in B* only. Therefore the loges* -log, B* results in an equal change on the scale of measure- 
ment for each increment of B* rather than the logarithmic change which occurs in the measure 
S*IB*. The transformed data are given in Fig. 5(a).  There is an obvious bimodality of the 
measure B*. 
The distributions of our measure of Lp antigen in sera which tested Lp(a + ) and sera which 
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Fig. 4. The distribution of the value #*/I?*. 
tested Lp(a - ) in Ouchterlony immunodiffusion when taken separately (Figs. 5 b,  c )  show that 
the threshold level for distinguishing between positive and negative reactors lies a t  a value of 
0.15 (log, = - 1.897). This value is also near the trough of the log, distribution in these experi- 
ments. There are no qualitatively negative reactors who have relative Lp quantities in their 
sera higher than this value. There is considerable overlap of positive and negative reactions in 
the log, 0.1 to log, 0.2 range. Such a large number of individual sera with Lp quantities appear- 
ing at the threshold level could explain the wide variation in Lp(a) phenotype frequencies 
found by different investigators in the same or similar populations (Sing, Schultz & Shreffler, 
1974). The combined effects of antisera with varying titres and individuals with varying antigen 
levels could have a considerable influence on phenotype frequency determinations. 
It would also appear that some antigen is present in the serum of each individual as has been 
shown previously (Harvie & Schultz, 1970)) although the lowest quantity is a t  most 1/50 of the 
highest. This quantitative variation makes i t  possible to explain the ability of Lp(a - ) serum to 
elicit an immune response (Schultz et al. 1968) and the ability of such a serum to absorb anti- 
Lp(a) activity. These sera contain a small quantity of Lp(a) antigen which is not detectable on 
immunodiffusion assay. 
In light of the quantitative variation in our measure of Lp levels t.he fact that two Lp(a) 
negative individuals, both having a level of antigen too low to be detected by Ouchterlony test, 
occasionally produce an Lp(a + ) child can be explained by several genetic models. The overlap- 
Genetics of the Lp antigen. I 45 
Fig. 5. The distribution of the log,S*/B*. (a) All cases; ( b )  Lp(a- ) ;  ( c )  Lp(a+).  
ping bimodal distributions strongly indicate that a major genetic factor is operating to  determine 
the modes. Variation within modes may be due to  one or a combination of factors including 
variation in the background genotype, environmental influences and measurement error. An 
in-depth analysis of the relative roles of these factors is presented in the second paper of this 
series (Sing et al. 1974). 
SUMMARY 
The frequency distribution of the quantitative activity of the Lp antigen was found to be 
bimodal. It is hypothesized that a major genetic factor is operating to  determine the modes. 
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